Tolerance and Pharmacokinetics of TQB2450
Clinical trial NCT03460457 · UNKNOWN
Trial details
- NCT number
- NCT03460457
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2019-03-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.